V. Costes et al., The Mi15 monoclonal antibody (anti-Syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens, HUMAN PATH, 30(12), 1999, pp. 1405-1411
Citations number
37
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Plasmocyte selective monoclonal antibodies (MAb) recognizing syndecan-1 hav
e recently been described. They belong to a new cluster, CD138. Using the M
Ab MI15, we investigated the expression of syndecan-1 in routinely paraffin
-embedded tissues. Nontumoral lymph nodes (25 cases) and bone marrow biopsy
specimens (63 cases) showed strong membrane staining of plasma cells only,
allowing accurate analysis of the nuclear structure. The MI15 positivity c
orrelated with kappa and lambda light chain expression in the cytoplasm. Th
e percentages of plasma cells calculated in bone marrow biopsy specimens af
ter MI15 staining were, respectively, 2.1% (range, 1% to 4%) in normal bone
marrows, 8.5% (range, 5 to 17) in reactive plasmocytosis, and 4.66% in mon
oclonal gammapathy of undetermined significance (MGUS) patients (range, 1 t
o 13), in the same range but slightly higher than those obtained on smears
or on hematoxylin and eosin (H&E)-stained sections. In multiple myeloma (40
cases), all plasma cell types were marked, and Mi15 MAb gave additional in
formation in 8 of 40 (20%) patients. In lymph nodes, Mi15 MAb reacted with
Reed-Sternberg cells of classical Hodgkin's disease in 23 of 31 cases (74%)
with variable intensity. In contrast, nodular lymphocyte predominance Hodg
kin's disease (10 cases), most B cell lymphomas (88 of 107 cases) and all T
cell lymphomas (30 cases) were negative. In B cell lymphomas, plasmocytoma
s (8 cases), plasmocytic lymphomas (2 cases), and 5 of 13 cases of immunobl
astic lymphoma with plasmocytoid differentiation were stained. In lymphopla
smocytoid lymphomas (4 lymph nodes and 20 bone marrow biopsy specimens), on
ly mature plasma cells were positive. Moreover, a wide distribution of synd
ecan-1 was observed in normal and tumoral epithelial tissues. Finally, Mi15
MAb appears to be a reliable marker for identifying and quantifying normal
and tumoral plasma cells in paraffin-embedded bone marrow and lymph node s
amples. Copyright (C) 1999 by W.B. Saunders Company.